AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Middle East Tumor Marker Sales Segment Forecasts for over 40 Tests, 2019: An 11-Country Analysis - ResearchAndMarkets.com

January 7, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 7, 2020--

The “Middle East Tumor Marker Sales Segment Forecasts for over 40 Tests: An 11-Country Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities” report has been added to ResearchAndMarkets.com’s offering.

This new 11-country report from the author is available by country, market segment, section, or individual test.

This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.

The report provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current and emerging assays; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Business Opportunities and Strategic Recommendations

Over 200 Current and Emerging Cancer Diagnostic Tests

Instrumentation Review

Technology Assessment

Competitive Strategies

The companies analyzed in the report include:

For more information about this report visit https://www.researchandmarkets.com/r/6r5ogk

View source version on businesswire.com:https://www.businesswire.com/news/home/20200107005510/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: MIDDLE EAST

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/07/2020 06:07 AM/DISC: 01/07/2020 06:07 AM

http://www.businesswire.com/news/home/20200107005510/en